Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 9th September 2024
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

University develops feline iPSCs without genetic footprint
The high-quality iPSCs could lead to discoveries for both veterinary and human medicine.
The discovery could improve therapies for chronic kidney disease.

Osaka Metropolitan University has become the first to produce high-quality feline induced pluripotent stem cells (iPSCs) without a genetic footprint.

The development of these new iPSCs could support the future of regenerative medicine for cats, including therapies for chronic kidney disease.

Although human iPSCs can be generated with four genes, known as transcription factors, feline iPSCs are considered more difficult to create.

In this project Shingo Hatoya, from the Graduate School of Veterinary Science, led a team to successfully generate feline iPSCs from six transcription factors. The transcription factors were introduced via the Sendai virus vector to create iPSCs from feline cells, including cells from the uterus that were donated after cats were sterilised.

The research team says that these iPSCs are the first high-quality iPSCs to be created in the world.

These stem cells exhibit the same properties as many iPS cells, including the ability to form teratomas with all three germ layers. This proves that the iPSCs are high quality and will be able differentiate into a variety of different cells.

The iPSCs do not have a genetic footprint, which lowers the chance that they will form tumours when implanted into another cat.

The cells can also be maintained without a feeder, such as fibroblast from mice, in chemically-defined conditions. This means that, because there is no need to mix cells from other species, the iPSCs are safer.

Further research into feline iPSCs could lead to a wider application of veterinary regenerative medicines, as well as advanced regenerative medicine research in humans.

Prof Hatoya said: “Especially in cats, chronic kidney disease and diabetes are serious problems,

“Establishing a method to have cells form a kidney or pancreas from feline iPSCs will be a challenge for future research.”

Prof Hatoya added: “High-quality feline iPSCs made possible by this research are expected to be provided to researchers around the world for use in veterinary regenerative medicine research, understanding of the pathophysiology of genetic diseases, and development of new therapeutic agents.”

The full study can be found in the journal Science Direct.

Image (C) Shutterstock

Become a member or log in to add this story to your CPD history

Webinar to explore history of KC breed registers

News Story 1
 A free webinar exploring the development of the Kennel Club's registration system and the evolution of closed breed registers has been announced.

Hosted by Dr Alison Skipper, veterinary and research advisor at the Kennel Club, the webinar will delve into the development of the registry and how the changing landscape of scientific knowledge has shaped breeding practices. It will also look at what this means for the future of pedigree dogs.

The session will culminate with a look at The Kennel Club's ongoing and future engagement in this area, with a chance for attendees to put forward their thoughts and questions for discussion.

This event takes place on Microsoft Teams on Tuesday, 10 June at 7pm. To learn more, visit events.teams.microsoft.com  

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.